Capital Enterprises, a Carestream distributor, transported and installed a Carestream Vita Flex CR System that provides imaging services to 8,000 local residents as well as mountaineers, sherpas and others who support those who dare to climb Mount Everest.

Ikonopedia will introduce its next-generation breast ultrasound reporting module at the 2018 Society for Breast Imaging (SBI)/American College of Radiology (ACR) Breast Imaging Symposium, April 12-15 in Las Vegas. The new and intuitive, Breast Imaging-Reporting and Data System (BI-RADS)-compliant interface is designed to streamline reporting for both screening and diagnostic exams acquired with both automated breast ultrasound (ABUS) and handheld ultrasound. Ikonopedia will demonstrate its complete suite of breast imaging structured reporting tools at SBI.

Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-adaptive (OA) approach together with the CyberKnife System. The patient, treated for oligometastases in the pelvic region, is part of a new clinical trial conducted at Erasmus MC, the largest university medical center in the Netherlands, evaluating OA stereotactic body radiation therapy (SBRT) delivered by the CyberKnife platform. The trial brings the hospital one step closer to its goal of providing individual, personalized medicine.

April 5, 2018 — Medical imaging company Brainomix has attracted £7m ($9.8 million) of investment to bring its artificial ...

Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy System at MedStar Georgetown University Hospital in Washington, D.C.

The American Society for Radiation Oncology (ASTRO) issued an update to its clinical guideline for the use of palliative-intent radiation therapy for patients with incurable non-small cell lung cancer (NSCLC). Reflecting new evidence from randomized clinical trials, the guideline now recommends the addition of concurrent chemotherapy to radiation therapy for certain patients with incurable stage III NSCLC, including those who are able to tolerate chemotherapy and have a life expectancy longer than three months.

Optical mammography (OM), which uses harmless red or infrared light, has been developed for use in conjunction with X-rays for diagnosis or monitoring in cases demanding repeated imaging where high amounts of ionizing radiation should be avoided. At the OSA Biophotonics Congress: Biomedical Optics meeting, held April 3-6 in Hollywood, Fla., researchers from Milan, Italy, will report an advance in instrument development that increases the sensitivity of OM by as much as 1,000-fold.

Results from a recent prospective trial found the Wide Area Transepithelial Sampling with 3D Tissue Analysis (WATS3D) device increases the detection of both Barrett’s esophagus and esophageal dysplasia by more than 80 percent. Study results from the multicenter trial of more than 4,000 patients were published in the latest issue of United European Gastroenterology Journal and featured in the American Society for Gastrointestinal Endoscopy (ASGE)’s Scope Tech Talk video series.